A study on Cleveland Clinic’s mobile stroke unit reveals one characteristic that seems to particularly drive early IV thrombolysis delivery.
Practice may not make perfect in healthcare, but it can sure make for greater efficiency and effectiveness. This study of our mobile stroke unit’s evolution over three years is a case in point.
In this case study, uveitis specialist Careen Lowder, MD, PhD, outlines her approach to treating an increasingly common food-borne eye infection.
Checkpoint inhibitor therapy for cancer holds great potential for durable response rates, but immune-related adverse events may be its Achilles’ heel.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A Cleveland Clinic study presented at the 2018 International Stroke Conference suggests these units may help bypass interhospital transfers for patients requiring thrombectomy.
Findings from the first study to examine the importance of treating in the “golden hour” specifically in the setting of ELVO strokes could reshape thinking around ELVO management.
The answer is yes, according to a new national database analysis, but the differences are limited and fairly focused on promptness of reperfusion therapy.
The newly published DEFUSE 3 trial joins the DAWN trial in support of extending the time window for endovascular thrombectomy in selected patients with acute ischemic stroke.
Something’s going right in acute stroke therapy: Medicare data show that one-year mortality fell 18 percent from 2009 to 2013 in tandem with a 60 percent rise in IV tPA use.
Ancillary study to STAMPEDE study measures the five-year outcomes of bariatric surgery versus guideline-recommended intensive medical therapy on bone turnover in obese patients.